Metazym for the Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD) - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

Metazym for the Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)

This study is ongoing, but not recruiting participants.
Information provided by Zymenex A/S

Please refer to this study by its ClinicalTrials.gov identifier: NCT00418561

Locations


Denmark
	PhaseOneTrials A/S
	Hvidovre, Denmark, DK-2650

Sponsors and Collaborators

Zymenex A/S

Investigators


Principal Investigator:	Allan M Lund, MD	Rigshospitalet, Denmark